REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/18/2026
Back to search
Official data from USPTO
NEONET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEONET
ST13
US500000087581872Class
35, 42, 44
Filing
87581872
Registration
6356240
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
74
Latest update
05/19/2026
Trademark type
Word
Nice classes
35, 42, 44
Filing date
08/24/2017
Registration date
05/18/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/18/2021
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2016-00-00
First use in commerce
2016-00-00
Drawing code
4
Owner type
03
Owner location
Fort Myers, FL, US
Examiner
DUBOIS, SUSAN L
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc.
Representatives
Anessa O. Kramer Honigman LLP
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Compilation and systemization of information into computer database(s)
Class 42
Genetic mapping for scientific purposes; gene sequencing; molecular sequencing; cancer study and analysis; clinical study and testing of cells; medical and scientific research information in the field of gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cells; scientific research in the field of gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cellscancer; providing information to others in the fields of oncologypathology and gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencingmolecular sequencingcancer study and analysisclinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research servicesmedical research servicesclinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research servicesmedical research servicesclinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysisresearchreview of information pertaining to medicalscientificgenetictesting and analysisinformation and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for enhancement of analysisresearchreview of information pertaining to medicalscientificgenetictesting and analysisinformation pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology ; genetic testingrna testing and sequencing; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory servicesoncology reference laboratory servicesproviding informationinteractive informationreportsto others in the field of pathologydiagnostic testingoncology testing; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; medical and scientific researchconducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; providing an interactive website that allows users to enteraccesssynthesize information and generate reports pertaining to medical and scientific testing and analysis; providing medical and scientific research information in the fields of pharmaceuticals and genetics; providing information in the field of oncology; providing laboratory information for medical and scientific purposes
Class 44
Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human diseasehuman medical conditionsmedical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human diseasehuman medical conditionsmedical diagnostic testing servicesmedical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human diseasehuman medical conditionsmedical diagnostic testing servicesmedical testing for diagnostic or treatment purposes; medical testing for the detection of cancer; medical testing for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosisprognosis and therapy selection; oncology reference laboratory services; medical and scientific information servicesproviding information in the field of medical testingclinical testingscientific researchreporting of clinical testing results directly to the patient; providing medical information; providing medical testing information; providing scientific information in the field of human disease and medical testing in relation thereto
Publications
History of USPTO decisions and trademark events.
74 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/01/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/01/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/10/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/10/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/10/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/10/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/13/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/13/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/13/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/18/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/14/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/13/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/31/2021
IUAF
USE AMENDMENT FILED
03/26/2021
EISU
TEAS STATEMENT OF USE RECEIVED
03/26/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/26/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/26/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/26/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/26/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/22/2020
EX5G
SOU EXTENSION 5 GRANTED
09/21/2020
EXT5
SOU EXTENSION 5 FILED
09/16/2020
EEXT
SOU TEAS EXTENSION RECEIVED
09/16/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/16/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/16/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/16/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/16/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/16/2020
DOCK
ASSIGNED TO EXAMINER
07/23/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/04/2020
EX4G
SOU EXTENSION 4 GRANTED
02/03/2020
EXT4
SOU EXTENSION 4 FILED
01/31/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/31/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/27/2019
EX3G
SOU EXTENSION 3 GRANTED
09/26/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/26/2019
EXT3
SOU EXTENSION 3 FILED
09/23/2019
EEXT
SOU TEAS EXTENSION RECEIVED
09/23/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/27/2019
EX2G
SOU EXTENSION 2 GRANTED
02/25/2019
EXT2
SOU EXTENSION 2 FILED
02/25/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/25/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/29/2018
EX1G
SOU EXTENSION 1 GRANTED
05/25/2018
EXT1
SOU EXTENSION 1 FILED
05/25/2018
EEXT
SOU TEAS EXTENSION RECEIVED
05/25/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/27/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/30/2018
PUBO
PUBLISHED FOR OPPOSITION
01/30/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/10/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/23/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/22/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/21/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/21/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/18/2017
GNRT
NON-FINAL ACTION E-MAILED
12/18/2017
CNRT
NON-FINAL ACTION WRITTEN
12/18/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/16/2017
ALIE
ASSIGNED TO LIE
12/15/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/02/2017
GNRT
NON-FINAL ACTION E-MAILED
12/02/2017
CNRT
NON-FINAL ACTION WRITTEN
12/02/2017
DOCK
ASSIGNED TO EXAMINER
11/29/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/29/2017
NWAP
NEW APPLICATION ENTERED
08/28/2017
Continuous trademark protection
Get notified about every new filing that threatens NEONET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.